Development of fludarabine formulations in the treatment of chronic lymphocytic leukemia
Ann Janssens, Marc Boogaerts, Gregor VerhoefDepartment of Hematology, University Hospitals Leuven, Campus Gasthuisberg, Leuven, BelgiumAbstract: Fludarabine is an antineoplastic agent used in the treatment of hematological malignancies, particularly chronic lymphocytic leukemia (CLL) and indolent B-...
Saved in:
Main Authors: | Ann Janssens (Author), Marc Boogaerts (Author), Gregor Verhoef (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2009-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Individual features of the pharmacokinetics of fludarabin phosphate in the treatment of patients with chronic lymphocytic leukemia
by: G. G. Rodionov, et al.
Published: (2021) -
Evaluación económica de rituximab en combinación con fludarabina y ciclofosfamida en comparación con fludarabina y ciclofosfamida en el tratamiento de la leucemia linfática crónica Economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia
by: Luis Felipe Casado, et al.
Published: (2011) -
New developments in the treatment of chronic lymphocytic leukemia: role of obinutuzumab
by: Shah A
Published: (2015) -
Fe de errores de "Evaluación económica de rituximab en combinación con fludarabina y ciclofosfamida en comparación con fludarabina y ciclofosfamida en el tratamiento de la leucemia linfática crónica" Erratum to "Economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia"
by: Luis Felipe Casado, et al.
Published: (2011) -
Chronic Lymphocytic Leukemia
Published: (2012)